Krystal Biotech (KRYS) Assets (2016 - 2026)
Krystal Biotech's Assets came in at $1.5 billion for Q2 2026, up 31.8% from $1.14 billion a year earlier and up 7.4% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Krystal Biotech's Assets was $1.33 billion, up 26.3% from FY2024.
- Assets has increased in each of the last three years, with a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
- Going back by year, Assets was $1.06 billion in FY2024 (+29.0%), $818.36 million in FY2023 (+46.5%), $558.45 million in FY2022 (-10.8%) and $626.3 million in FY2021 (+101.5%).
- The Q2 2026 figure represents the highest quarterly Assets in data going back to Q4 2016.
- Year-over-year, Assets has increased for 13 consecutive quarters, with growth averaging 27.2% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 101.5%), and the weakest in Q1 2023 (a decline of 13.8%).
- Business Quant data shows KRYS's Assets at $1.4 billion (Q1 2026), $1.33 billion (Q4 2025) and $1.24 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 1.50 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.50 Bn |
| Mar 31, 2026 | 1.40 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 1.07 Bn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 982.32 Mn |
| Jun 30, 2024 | 917.66 Mn |
| Mar 31, 2024 | 853.30 Mn |
| Dec 31, 2023 | 818.36 Mn |
| Sep 30, 2023 | 790.35 Mn |
| Jun 30, 2023 | 684.03 Mn |
| Mar 31, 2023 | 531.85 Mn |
| Dec 31, 2022 | 558.45 Mn |
| Sep 30, 2022 | 576.38 Mn |
| Jun 30, 2022 | 601.32 Mn |
| Mar 31, 2022 | 616.87 Mn |
| Dec 31, 2021 | 626.30 Mn |
| Sep 30, 2021 | 451.10 Mn |
API Access
Krystal Biotech Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();